
7.2.1
Steps in the Cycle
Let us take a course through the mammalian cell cycle starting in the G1 phase. As
the level of G
1
cyclins rises, they bind to their CDKs and signal the cell to prepare
the chromosomes for replication. When the level of S phase–promoting factor (SPF)
rises, which includes cyclin A bound to CDK2, it enters the nucleus and prepares the
cell to duplicate its DNA (and its centrosomes). As DNA replication continues, cyclin
E is destroyed, and the level of mitotic cyclins begins to increase (in G
2
). The M
phase–promoting factor (the complex of mitotic cyclins with the M-phase CDK) initi-
ates (1) assembly of the mitotic spindle, (2) breakdown of the nuclear envelope, and
(3) condensation of the chromosomes. These events take the cell to metaphase of mi-
tosis. At this point, the M phase–promoting factor activates the APC, which allows
the sister chromatids at the metaphase plate to separate and move to the poles (ana-
phase), thereby completing mitosis. APC destroys the mitotic cyclins by coupling
them to ubiquitin, which targets them for destruction by proteasomes. APC turns on
the synthesis of G
1
cyclin for the next turn of the cycle and it degrades geminin, a
protein that keeps the freshly synthesized DNA in the S phase from being re-repli-
cated before mitosis.
A number of checkpoints ensure that all processes connected with cell cycle pro-
gression and DNA doubling and separation occur correctly. At these checkpoints,
the cell cycle can be aborted or arrested. They involve checks on completion of the S
phase, on DNA damage, and on failure of spindle behavior. If the damage is irrepar-
able, apoptosis is triggered. An important checkpoint in G
1
has been identified in
both yeast and mammalian cells. Referred to as “start” in yeast and as “restriction
point” in mammalian cells, this is the point at which the cell becomes committed to
DNA replication and completing a cell cycle (Hartwell 1974; Hartwell et al. 1974;
Pardee 1974; Nurse 1975). All the checkpoints require the services of complexes of
proteins. Mutations in the genes encoding some of these proteins have been asso-
ciated with cancer. These genes are regarded as oncogenes. Failures in checkpoints
permit the cell to continue dividing despite damage to its integrity. Understanding
how the proteins interact to regulate the cell cycle became increasingly important to
researchers and clinicians when it was discovered that many of the genes that en-
code cell cycle regulatory activities are targets for alterations that underlie the devel-
opment of cancer. Several therapeutic agents, such as DNA-damaging drugs, micro-
tubule inhibitors, antimetabolites, and topoisomerase inhibitors, take advantage of
this disruption in normal cell cycle regulation to target checkpoint controls and ulti-
mately induce growth arrest or apoptosis of neoplastic cells.
For the presentation of modeling approaches, we will focus on the yeast cell cycle
since intensive experimental and computational studies have been carried out using
different types of yeast as model organisms. Mathematical models of the cell cycle
can be used to tackle, for example, the following relevant problems.
1. The cell seems to monitor the volume ratio of nucleus and cytoplasm and to trig-
ger cell division at a characteristic ratio. During oogenesis, this ratio is abnormally
235
7.2 Cell Cycle